UAE Anti Aging Therapeutics Market Report 2022 to 2030

UAE Anti Aging Therapeutics Market Analysis

$ 3999

UAE anti-aging therapeutics market is projected to grow from $3 Mn in 2022 to $11 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. The market is projected to expand as a result of the growing demand for anti-aging treatments and rising disposable incomes in the UAE. The UAE anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Insilico Medicine, Kuwait Saudi Pharmaceuticals, and Alkahest are the top players in the market.

ID: IN10AEPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Parul Choudhary

Buy Now

UAE Anti-Aging Therapeutics Market Executive Summary

The UAE anti-aging therapeutics market size is at around $3 Mn in 2022 and is projected to reach $11 Mn in 2030, exhibiting a CAGR of 17.53% during the forecast period. The future holds growth for Dubai's healthcare industry. According to the Dubai Chamber of Commerce and Industry, revenue generated within the overall UAE healthcare sector is anticipated to increase by 7.5% annually to hit $10.7 Bn by 2025. Meanwhile, it is anticipated that healthcare expenditure will increase to 4.6% of GDP by 2026 and 5.1% of GDP by 2029. With increased government initiatives, the UAE healthcare industry is expanding at an astounding rate. Additionally, the UAE government is significantly enhancing and extending its healthcare system in order to create a powerful, top-notch healthcare infrastructure. To improve the current infrastructure and match the calibre of services provided in developed nations, the government is also encouraging private sector involvement.

Since the beginning of time, aging has been a fact of existence. Humans go through different stages of life, from childhood to adolescence to adulthood, with youth being the finest stage from a health perspective. Ideal youth is characterized by good health, lean muscles, a powerful immune system, good memory, and a healthy brain. The teenage years are when the hormones are functioning at their highest level. Anti-aging medicine aims to maintain or achieve this, i.e., to remain healthy and biologically effective, regardless of chronological age.

In the UAE, the market for anti-aging medicines is expanding. Due to the rapidly aging population in the UAE, there is an increasing need for anti-aging therapies and treatments. The UAE offers a variety of anti-aging treatments, including hormone replacement therapy (HRT), which is a popular anti-aging treatment there. HRT is used to replenish the body's dwindling hormone levels, which can happen as we age. Injections of Botox and dermal fillers are frequently used to hide creases and fine lines on the face. In the UAE, these therapies are offered at numerous clinics and hospitals. Stem cells are used in stem cell therapy, a more recent anti-aging procedure, to heal and replace the body's damaged tissues. Some specialist clinics and hospitals in the UAE offer stem cell therapy. In the UAE, a wide variety of nutraceuticals and dietary supplements are promoted as anti-aging products. These supplements might include nutrients, vitamins, or antioxidants supposed to have anti-aging qualities.

UAE Anti Aging Therapeutics Market

Market Dynamics

Market Growth Drivers Analysis

The UAE anti-aging therapeutics market is significantly fueled by the UAE's increasing elderly population. The demand for anti-aging treatments is predicted to increase along with the aging population. The UAE has a growing middle class and a high per capita income, which is anticipated to increase demand for anti-aging medications. People are more apt to spend on anti-aging treatments as their disposable income increases. Many people journey to the UAE for medical treatment, making it an appreciated medical tourism destination. The desire for anti-aging treatments in the nation is anticipated to increase as a result.

Market Restraints

Many people in the UAE may not be able to afford anti-aging therapies due to their high cost. The UAE anti-aging therapeutics market may be significantly constrained by this. The regulatory environment in the UAE might also be a barrier to the market's expansion for anti-aging medicines. The use and distribution of these therapies may be subject to stringent rules and standards, which could reduce their accessibility.

Competitive Landscape

Key Players

NewBridge Pharmaceuticals (ARE)
AngelWorld Biotech (ARE)
Insilico Medicine (ARE)
Kuwait Saudi Pharmaceuticals (ARE)
Alkahest
Athersys
BHB Therapeutics
Biosplice
Cyclo Therapeutics
Denali Therapeutics
Elysium Health
Genome Protection
GenSight Biologics

Healthcare Policies and Regulatory Landscape

The Ministry of Health and Prevention (MoHAP) is the regulatory authority in charge of approving and regulating medications in the UAE, including anti-aging medications. MoHAP is the principal agency in charge of regulating the UAE's healthcare industry and ensuring the effectiveness and safety of pharmaceuticals, including anti-aging medications. A drug must go through a rigorous evaluation procedure by MoHAP in order to be approved for use in the UAE, including anti-aging medications. Pre-clinical and clinical trials are performed as part of the evaluation process to judge the drug's quality, efficacy, and safety. After a drug has been approved and introduced to the market, MoHAP continues to watch its security. For the purpose of identifying and assessing adverse drug reactions and ensuring that medications remain secure and efficient, it established a pharmacovigilance system. The Dubai Health Authority (DHA), in addition to the MoHAP, is in charge of governing the healthcare industry in the city of Dubai. In Dubai, the DHA is also involved in the licensing and control of medications, including anti-aging medications.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

Anti-Wrinkle
Hair Color
Ultraviolet (UV) Absorption
Anti-Stretch Mark
Others

By Treatment (Revenue, USD Billion):

Hair Restoration
Anti-Pigmentation
Adult Acne Therapy
Breast Augmentation
Liposuction
Chemical Peel
Others

By Target Group (Revenue, USD Billion):

Male
Female

By Type of Aging (Revenue, USD Billion):

Cellular Aging
Immune Aging
Metabolic Aging
Others

By Type of Molecules (Revenue, USD Billion):

Biologics
Small Molecules

By Mechanism of Action (Revenue, USD Billion):

Senolytic
Cell Regeneration
mTOR inhibitor/Modulator
AMP-kinase/AMP Activator
Mitochondria Inhibitor/Modulator
Others

By Ingredient (Revenue, USD Billion):

Retinoid
Hyaluronic Acid
Alpha Hydroxy Acid
Others

By Distribution Channel (Revenue, USD Billion):

Pharmacies
Stores
Online Stores

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.